Every material Form 8-K Corteva has filed with the SEC since February 05, 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Corteva disclosed board and officer changes tied to its Separation, effective at the Effective Time. Luther (Luke) Kissam became Chief Executive Officer and Jeff Rudolph became Chief Financial Officer, and four directors resigned from the board. Shareholders will be watching how the new leadership team and reshaped board guide the company after the Separation.
Luther (Luke) Kissam was appointed Chief Executive Officer, and Jeff Rudolph was appointed Chief Financial Officer, effective as of the Effective Time.
Charles V. Magro, Kerry J. Preete, Marcos M. Lutz and Karen H. Grimes resigned from the Board, with Magro also leaving his officer roles.
Kissam was appointed as a director, and Brook Cunningham and Ralph Ford were named Chief Commercial Officer and Chief Integrated Operations Officer.
Corteva completed the separation of its seed operating segment into an independent public company, Vylor Inc., through a pro rata share distribution effective October 1, 2026. Vylor common stock began regular-way trading on the New York Stock Exchange under the symbol VYLR that day, and Corteva entered several agreements with Vylor governing the split, including tax, employee, transition services, and intellectual property terms.
Distribution record date was September 24, 2026; Vylor shares trade on the NYSE as VYLR from October 1, 2026
Separation and Distribution Agreement dated September 29, 2026; Tax Matters, Employee Matters, Reverse Transition Services, Intellectual Property Matters, and Global Master Seed Treatment Supply agreements dated October 1, 2026
Certain schedules omitted under Item 601(a)(5) of Regulation S-K; the filing does not give financial figures for the spin-off
Corteva's subsidiary EIDP entered a supplemental indenture on August 20, 2026, that removes most restrictive covenants and events of default from its notes, with the changes taking effect only when Vylor's exchange offers settle alongside the separation. The filing says the amendments were approved by the required majority of noteholders as of August 19, 2026, and would not take effect if the separation is not completed.
On August 20, 2026, EIDP entered a fourth supplemental indenture with U.S. Bank Trust Company as trustee.
The proposed amendments would eliminate substantially all restrictive covenants and events of default, other than payment and bankruptcy-related defaults.
Vylor received the required consents from noteholders as of August 19, 2026; the amendments become operative only at settlement of the exchange offers, expected alongside the separation.
Corteva reported second-quarter 2026 net sales of $6.38 billion, down 1% from a year earlier, and GAAP earnings per share from continuing operations of $1.81, down 10%. Non-GAAP operating EBITDA rose 4% to $2.26 billion and operating EPS rose 5% to $2.30, and the company raised its full-year 2026 guidance to operating EBITDA of $4.1 billion to $4.3 billion and operating EPS of $3.60 to $3.80 per share.
Q2 2026 net sales were $6.38 billion, down 1%; organic sales fell 2%
GAAP EPS from continuing operations was $1.81 versus $2.02 in the year-earlier quarter; GAAP income from continuing operations after taxes was $1.22 billion
Full-year 2026 operating EBITDA guidance is $4.1 billion to $4.3 billion; operating EPS guidance is $3.60 to $3.80 per share
The planned separation remains on track for an October 1, 2026 spin-off of Vylor, with an Investor Day on September 15, 2026
Four Corteva directors, Karen Grimes, Marcos Lutz, Charles Magro and Kerry Preete, agreed to resign from the Corteva board effective immediately before the planned spin-off of the seed business into Vylor, Inc. The filing says each is expected to join the Vylor board, and the resignations are not tied to any disagreement with the company. The companies also announced their post-separation boards, and the separation remains on track for the fourth quarter of 2026.
Resignations agreed June 26, 2026, and take effect only if the spin-off is completed
Greg Page to chair a nine-person Corteva board; Luke Kissam to join at separation
Karen Grimes to chair a seven-director Vylor board; a search is ongoing for at least one more member
Vylor filed its first Form 10 registration statement with the SEC; separation on track for 4Q 2026
Corteva reported first-quarter 2026 net sales of $4.9 billion, up 11% from a year earlier, and GAAP earnings per share from continuing operations of $1.07 versus $0.97. The company reaffirmed its full-year 2026 guidance, which keeps Operating EBITDA at $4.0 billion to $4.2 billion and Operating EPS at $3.45 to $3.70, while the planned separation remains on track for the second half of 2026.
Net sales were $4.9 billion, up 11%; organic sales rose 7%.
GAAP EPS from continuing operations was $1.07, up from $0.97; Operating EPS was $1.50, up 33%.
Full-year 2026 guidance reaffirmed: Operating EBITDA $4.0 billion to $4.2 billion; Operating EPS $3.45 to $3.70.
The company plans to repurchase about $500 million of shares in the first half of 2026.
Corteva named Luke Kissam, former Albemarle chairman, president and CEO, as CEO of New Corteva, the crop protection company that will separate from its seed business, SpinCo, in the fourth quarter of 2026. Kissam joins the company June 1, 2026, and Chief Executive Chuck Magro will become SpinCo CEO at separation, with new executive teams named for both companies. The filing discloses no financial results; the changes set the leadership structure for the planned separation.
Luke Kissam, 61, joins June 1, 2026 as CEO of the Crop Protection Business Unit and becomes New Corteva CEO at separation.
Kissam's employment agreement sets a $1.2 million annual base salary, a 150% short-term incentive target, and a one-time 2026 equity award with a $3.75 million target grant date value.
Jeff Rudolph is named New Corteva CFO; David Johnson becomes SpinCo CFO; Magro becomes SpinCo CEO.
Robert King, Executive Vice President of Crop Protection, becomes a strategic advisor July 1, 2026, and leaves after 2026 year-end, eligible for a $1 million transition bonus.
Corteva reported fourth-quarter 2025 net sales of $3.91 billion, down 2%, and a GAAP loss from continuing operations of $537 million, or $0.80 per share. For full-year 2025, net sales rose 3% to $17.40 billion and GAAP income from continuing operations rose 40% to $1.20 billion, or $1.75 per share. The company also expects 2026 operating EBITDA of $4.0 billion to $4.2 billion and operating EPS of $3.45 to $3.70 per share.
Q4 2025 operating EPS was $0.22, down 31% from the prior year, and operating EBITDA was $446 million, down 15%.
FY 2025 operating EPS was $3.34, up 30%, and free cash flow was $2.9 billion, a 69% improvement.
A Bayer litigation resolution involves a $610 million cash outflow, largely in the first quarter of 2026.
Corteva remains on track to complete its planned separation in the second half of 2026.
Corteva reported third-quarter net sales of $2.62 billion, up 13% from a year earlier, and a GAAP loss from continuing operations of $308 million, narrower than the $519 million loss in the prior-year quarter. The company raised its full-year 2025 guidance, now expecting operating EPS of $3.25 to $3.35 per share and operating EBITDA of $3.8 billion to $3.9 billion. Shareholders will also be watching the planned separation into two independent public companies, expected in the second half of 2026.
Q3 2025 net sales were $2.62 billion, up 13% from $2.33 billion in Q3 2024 (organic sales up 11%).
Q3 2025 GAAP loss from continuing operations after tax was $308 million, versus a $519 million loss in Q3 2024.
Full-year 2025 guidance: net sales $17.7 billion to $17.9 billion, operating EBITDA $3.8 billion to $3.9 billion, operating EPS $3.25 to $3.35 per share.
Company expects to repurchase approximately $1.0 billion of shares in 2025 and plans to separate into two companies in the second half of 2026.
Corteva announced a plan to separate into two independent, publicly traded companies through a tax-free spin-off. The company's current Crop Protection business would form New Corteva, and its Seed business would form SpinCo, with completion expected in the second half of 2026, subject to conditions. The company reaffirmed its full-year 2025 guidance, so the announcement does not change the 2025 outlook it gave shareholders.
New Corteva is estimated to have 2025 net sales of $7.8 billion, or 44% of Corteva's net sales.
SpinCo is estimated to have 2025 net sales of $9.9 billion, or 56% of Corteva's net sales.
The transaction is expected to be completed in the second half of 2026, and Corteva may abandon or change the separation at any time before completion.
Corteva reaffirmed full-year 2025 guidance and will host an investor call on October 1, 2025, at 8:30 a.m. Eastern Daylight Time.
Corteva appointed Jennifer Johnson, formerly general counsel at International Flavors & Fragrances, as chief legal officer effective September 15, 2025. Cornel Fuerer, the current chief legal and public affairs officer, will retire as an executive officer on that date and remain a strategic advisor until 2026. The change is a planned leadership succession and does not include any reported financial results.
Jennifer A. Johnson, age 50, becomes senior vice president, chief legal officer on September 15, 2025
Cornel Fuerer retires as executive officer effective September 15, 2025, and stays on as corporate secretary and public affairs overseer until the end of 2025
Johnson takes over the corporate secretary role and public affairs oversight from Fuerer before the end of 2025
Fuerer serves as strategic advisor until his retirement in 2026, at a time yet to be determined
Corteva reported second-quarter 2025 net sales of $6.46 billion, up 6% from a year earlier, and GAAP earnings per share from continuing operations of $2.02, up from $1.51. The company raised its full-year 2025 guidance, citing a strong first half and expected second-half growth, which points to higher expected earnings for shareholders.
2Q net sales were $6.46 billion, up 6%; GAAP EPS from continuing operations was $2.02 versus $1.51 a year earlier.
2Q operating EPS was $2.20, up 20%, and operating EBITDA was $2.16 billion, up 13%.
Full-year 2025 operating EPS guidance is $3.00 to $3.20; net sales guidance is $17.6 billion to $17.8 billion.
The company expects to repurchase approximately $1 billion of shares during 2025.
Corteva reported first-quarter 2025 results, with net sales down 2% to $4.42 billion while GAAP earnings per share from continuing operations rose to $0.97 from $0.53. The company reaffirmed its full-year 2025 guidance, including net sales of $17.2 to $17.6 billion and operating EPS of $2.70 to $2.95, which matters to shareholders because profit grew faster than sales while the outlook was left unchanged.
Net sales were $4.42 billion, down 2% from $4.49 billion a year earlier; organic sales rose 3%.
GAAP EPS from continuing operations was $0.97 versus $0.53; operating EPS was $1.13, up 27%.
Full-year 2025 guidance reaffirmed: net sales $17.2 to $17.6 billion, operating EBITDA $3.6 to $3.8 billion, operating EPS $2.70 to $2.95.
The company plans to repurchase approximately $1 billion of shares during 2025.
Corteva said director Rebecca Liebert will resign from its Board effective February 28, 2025, and will not stand for re-election at the 2025 Annual Meeting. The company said her decision is not the result of any disagreement with management or the Board, and the Board reduced its size from thirteen to twelve directors.
Rebecca Liebert, Ph.D. notified the Board on February 13, 2025 that she intends to pursue other opportunities.
Her resignation is effective February 28, 2025, and she will not stand for re-election at the 2025 Annual Meeting of Stockholders.
The filing states the resignation is not due to any disagreement with management or the Board on operations, policies, or practices.
The Board reduced its size from thirteen to twelve directors.
Corteva reported fourth-quarter 2024 net sales of $4.0 billion, up 7% from a year earlier, and a GAAP loss from continuing operations of $50 million, smaller than the $231 million loss in the prior-year quarter. For full-year 2024, net sales fell 2% to $16.9 billion and GAAP diluted EPS from continuing operations was $1.22, down from $1.30, while the company refined its 2025 net sales and Operating EPS outlook for currency effects and expects to repurchase about $1 billion of shares in 2025.
Q4 2024 net sales were $3,978 million, up 7%; Q4 GAAP loss from continuing operations was $50 million versus $231 million a year earlier.
Full-year 2024 net sales were $16,908 million, down 2%; GAAP diluted EPS from continuing operations was $1.22 versus $1.30 in 2023.
2025 guidance: net sales of $17.2 billion to $17.6 billion and Operating EPS of $2.70 to $2.95 per share, refined for the stronger U.S. dollar.
The company expects to repurchase approximately $1 billion of shares during 2025 and records approximately $150 million to $165 million in 2025 restructuring charges.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Corteva filing is on SEC EDGAR ↗. 8-K briefs of other companies →